Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Autoantibody profiling in multiple sclerosis reveals novel antigenic candidates.

Somers V, Govarts C, Somers K, Hupperts R, Medaer R, Stinissen P.

J Immunol. 2008 Mar 15;180(6):3957-63.

2.

Analysis of antibody reactivity in paired cerebrospinal fluid and serum of a relapsing remitting multiple sclerosis patient.

Govarts C, Somers K, Hupperts R, Stinissen P, Somers V.

Autoimmunity. 2009;42(8):699-704. doi: 10.3109/08916930903176513.

PMID:
19835487
3.

Multiplexing approaches for autoantibody profiling in multiple sclerosis.

Somers K, Govarts C, Stinissen P, Somers V.

Autoimmun Rev. 2009 Jun;8(7):573-9. doi: 10.1016/j.autrev.2009.02.001. Epub 2009 Feb 9. Review.

PMID:
19393211
4.

Investigation of autoantibody profiles for cerebrospinal fluid biomarker discovery in patients with relapsing-remitting multiple sclerosis.

Beyer NH, Lueking A, Kowald A, Frederiksen JL, Heegaard NH.

J Neuroimmunol. 2012 Jan 18;242(1-2):26-32. doi: 10.1016/j.jneuroim.2011.08.013. Epub 2011 Dec 15.

PMID:
22177943
5.

Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.

Lily O, Palace J, Vincent A.

Brain. 2004 Feb;127(Pt 2):269-79. Epub 2003 Dec 8.

PMID:
14662514
6.

Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool.

Lefranc D, Almeras L, Dubucquoi S, de Seze J, Vermersch P, Prin L.

J Immunol. 2004 Jan 1;172(1):669-78.

7.

Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.

Rouwette M, Somers K, Govarts C, De Deyn PP, Hupperts R, Van Wijmeersch B, De Jong BA, Verbeek MM, Van Pesch V, Sindic C, Villar LM, Álvarez-Cermeño JC, Stinissen P, Somers V.

J Neurochem. 2012 Nov;123(4):568-77. doi: 10.1111/jnc.12005. Epub 2012 Sep 28.

8.

Exploring cDNA phage display for autoantibody profiling in the serum of multiple sclerosis patients: optimization of the selection procedure.

Govarts C, Somers K, Hupperts R, Stinissen P, Somers V.

Ann N Y Acad Sci. 2007 Aug;1109:372-84.

PMID:
17785326
9.

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

Kerkar N, Choudhuri K, Ma Y, Mahmoud A, Bogdanos DP, Muratori L, Bianchi F, Williams R, Mieli-Vergani G, Vergani D.

J Immunol. 2003 Feb 1;170(3):1481-9.

10.

A novel protein highly expressed in testis is overexpressed in systemic sclerosis fibroblasts and targeted by autoantibodies.

Yasuoka H, Ihn H, Medsger TA Jr, Hirakata M, Kawakami Y, Ikeda Y, Kuwana M.

J Immunol. 2003 Dec 15;171(12):6883-90.

11.

A panel of candidate tumor antigens in colorectal cancer revealed by the serological selection of a phage displayed cDNA expression library.

Somers VA, Brandwijk RJ, Joosten B, Moerkerk PT, Arends JW, Menheere P, Pieterse WO, Claessen A, Scheper RJ, Hoogenboom HR, Hufton SE.

J Immunol. 2002 Sep 1;169(5):2772-80.

12.

Human transaldolase and cross-reactive viral epitopes identified by autoantibodies of multiple sclerosis patients.

Esposito M, Venkatesh V, Otvos L, Weng Z, Vajda S, Banki K, Perl A.

J Immunol. 1999 Oct 1;163(7):4027-32.

13.

Isolation and characterization of an oligodendrocyte precursor-derived B-cell epitope in multiple sclerosis.

Archelos JJ, Trotter J, Previtali S, Weissbrich B, Toyka KV, Hartung HP.

Ann Neurol. 1998 Jan;43(1):15-24.

PMID:
9450764
14.

Serum anti-Glc(alpha1,4)Glc(alpha) antibodies as a biomarker for relapsing-remitting multiple sclerosis.

Schwarz M, Spector L, Gortler M, Weisshaus O, Glass-Marmor L, Karni A, Dotan N, Miller A.

J Neurol Sci. 2006 May 15;244(1-2):59-68. Epub 2006 Feb 9.

PMID:
16480743
15.

Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.

Belogurov AA Jr, Kurkova IN, Friboulet A, Thomas D, Misikov VK, Zakharova MY, Suchkov SV, Kotov SV, Alehin AI, Avalle B, Souslova EA, Morse HC 3rd, Gabibov AG, Ponomarenko NA.

J Immunol. 2008 Jan 15;180(2):1258-67.

16.

Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.

Somers K, Stinissen P, Somers V.

Ann N Y Acad Sci. 2009 Sep;1173:92-102. doi: 10.1111/j.1749-6632.2009.04654.x.

PMID:
19758137
17.

Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.

Komori M, Matsuyama Y, Nirasawa T, Thiele H, Becker M, Alexandrov T, Saida T, Tanaka M, Matsuo H, Tomimoto H, Takahashi R, Tashiro K, Ikegawa M, Kondo T.

Ann Neurol. 2012 May;71(5):614-23. doi: 10.1002/ana.22633.

PMID:
22522477
18.
19.

Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis.

Dong-Si T, Weber J, Liu YB, Buhmann C, Bauer H, Bendl C, Schnitzler P, Grond-Ginsbach C, Grau AJ.

J Neurol. 2004 May;251(5):542-7.

PMID:
15164186
20.

Lipid-specific immunoglobulin M in CSF predicts adverse long-term outcome in multiple sclerosis.

Thangarajh M, Gomez-Rial J, Hedström AK, Hillert J, Alvarez-Cermeño JC, Masterman T, Villar LM.

Mult Scler. 2008 Nov;14(9):1208-13. doi: 10.1177/1352458508095729. Epub 2008 Aug 28.

PMID:
18755821

Supplemental Content

Support Center